Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Seizure|August 30, 2008
Non-convulsive status epilepticus; the rate of occurrence in a general hospitalR Alroughani, M Javidan, A Qasem, et al.BMJ Case Reports|October 17, 2014
Multiple sclerosis reactivation postfingolimod cessation: is it IRIS?R Alroughani, A Almulla, S Lamdhade, et al.ISRN Neurology|December 5, 2012
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald CriteriaR Alroughani, J Al Hashel, S Lamdhade, et al.Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 26, 2013
Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in KuwaitR Alroughani, J Al Hashel, A Thussu, et al.The Journal of Headache and Pain|June 26, 2020
Impact of primary headache disorder on quality of life among school students in KuwaitJasem Y Al-Hashel, R Alroughani, S Shuaibi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2013
Increasing prevalence and incidence rates of multiple sclerosis in KuwaitR Alroughani, S F Ahmed, R Behbahani, et al.Current Medical Research and Opinion|March 22, 2013
Consensus guidelines for the diagnosis and treatment of multiple sclerosisB Yamout, R Alroughani, M Al-Jumah, et al.Clinical Neurology and Neurosurgery|February 21, 2016
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in KuwaitR Alroughani, A Ashkanani, J Al-Hashel, et al.Current Medical Research and Opinion|May 7, 2015
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS)B Yamout, R Alroughani, M Al-Jumah, et al.European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.Pageof 3